Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS

Author： Sei Y.   Nishida K.   Kustova Y.   Markey S.P.   Morse H.C.   Basile A.S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.325, Iss.1, 1997-04, pp. : 81-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats

By Gimenez R.   Aguilar J.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 149-152

Elsevier

Access to resources Recommend Favorite

Ocular actions of platelet-activating factor: clinical implications

By Nitoda Eirini   Moschos Marilita M   Mavragani Clio P   Koutsilieris Michael  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Regional haemodynamic effects of platelet activating factor in the rat

By King K.A.   Lim S.L.   Pang C.C.Y.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Current status of platelet-activating factor antagonists

By Curtin M.L.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 703-711

Informa Healthcare

Access to resources Recommend Favorite

Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite